Naser Ansari-Pour

9PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsHaematological tumoursGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 02, 2023
Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.

Marni B McClure, Yasunori Kogure, Naser Ansari-Pour

|Oct 12, 2022
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.

Naser Ansari-Pour, Mehmet Samur, Erin Flynt

|Aug 11, 2022
Clonal diversification and histogenesis of malignant germ cell tumours.

Thomas R W Oliver, Lia Chappell, Rashesh Sanghvi

|Jul 19, 2022
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.

Sarah Gooding, Naser Ansari-Pour, Mohammad Kazeroun

|May 06, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.

Parvathi Sudha, Aarif Ahsan, Cody Ashby

|Nov 27, 2021
Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes.

Naser Ansari-Pour, Yonglan Zheng, Toshio F Yoshimatsu

Pageof 2

Frequent Collaborators

4 joint publications

David C Wedge

2 joint publications

Sarah Gooding

2 joint publications

Anjan Thakurta

2 joint publications

Kwee Yong